These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Desferrioxamine-related ocular toxicity: a case report. Simon S; Athanasiov PA; Jain R; Raymond G; Gilhotra JS Indian J Ophthalmol; 2012 Jul; 60(4):315-7. PubMed ID: 22824603 [TBL] [Abstract][Full Text] [Related]
6. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Baath JS; Lam WC; Kirby M; Chun A Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609 [TBL] [Abstract][Full Text] [Related]
7. Multimodal imaging in a case of deferoxamine-induced maculopathy. Gelman R; Kiss S; Tsang SH Retin Cases Brief Rep; 2014; 8(4):306-9. PubMed ID: 25372534 [TBL] [Abstract][Full Text] [Related]
8. Desferrioxamine related maculopathy: a case report. Arora A; Wren S; Gregory Evans K Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675 [TBL] [Abstract][Full Text] [Related]
9. [Poisoning of retinal pigment epithelium by deferoxamine. A case report]. Charton N; Sahel JA; Flament J Bull Soc Ophtalmol Fr; 1990; 90(6-7):599-602. PubMed ID: 2225255 [TBL] [Abstract][Full Text] [Related]
10. Desferrioxamine ototoxicity in an adult transfusion-dependent population. Chiodo AA; Alberti PW; Sher GD; Francombe WH; Tyler B J Otolaryngol; 1997 Apr; 26(2):116-22. PubMed ID: 9106087 [TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury due to deferoxamine in a renal transplant patient. Clajus C; Becker JU; Stichtenoth DO; Wortmann J; Schwarz A; Kielstein JT Nephrol Dial Transplant; 2008 Mar; 23(3):1061-4. PubMed ID: 18039640 [No Abstract] [Full Text] [Related]
12. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate. Somech R; Seaban-Adel K; Atkinson A; Kirby-Allen M Ann Allergy Asthma Immunol; 2007 Dec; 99(6):575-6. PubMed ID: 18219844 [No Abstract] [Full Text] [Related]
13. High risk of retinal damage by desferrioxamine in dialysis patients. Albalate M; Velasco L; Ortiz A; Monzú B; Casado S; Caramelo C Nephron; 1996; 73(4):726-7. PubMed ID: 8856289 [No Abstract] [Full Text] [Related]
14. Marrow proliferation as a cause of hearing loss in beta-thalassaemia major. Thio D; Prasad V; Anslow P; Lennox P J Laryngol Otol; 2008 Nov; 122(11):1253-6. PubMed ID: 17931455 [TBL] [Abstract][Full Text] [Related]
18. The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy. Kertes PJ; Lee TK; Coupland SG Can J Ophthalmol; 2004 Oct; 39(6):656-61. PubMed ID: 15559652 [No Abstract] [Full Text] [Related]
19. Successful desensitization of a case with desferrioxamine hypersensitivity. Gülen F; Demir E; Tanaç R; Aydinok Y; Gulen H; Yenigün A; Can D Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379 [TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury due to deferoxamine in a renal transplant patient. Hirschberg R; Bennett W; Scheinman J; Coppo R; Ponticelli C Nephrol Dial Transplant; 2008 Aug; 23(8):2704-5; author reply 2705. PubMed ID: 18515307 [No Abstract] [Full Text] [Related] [Next] [New Search]